Evaluation of Clinical Outcomes According to HER2 Detection by Fluorescence In Situ Hybridization in Women with Metastatic Breast Cancer Treated with Trastuzumab

2005 ◽  
Vol 6 (3) ◽  
pp. 240-246 ◽  
Author(s):  
Robert D. Mass ◽  
Michael F. Press ◽  
Steven Anderson ◽  
Melody A. Cobleigh ◽  
Charles L. Vogel ◽  
...  
Keyword(s):  
Breast Cancer ◽  
In Situ Hybridization ◽  
Metastatic Breast Cancer ◽  
Fluorescence In Situ Hybridization ◽  
Clinical Outcomes ◽  
Metastatic Breast

HER-2/neu Evaluation by Fluorescence in Situ Hybridization on Destained Cytologic Smears from Primary and Metastatic Breast Cancer

2005 ◽  
Vol 49 (1) ◽  
pp. 27-30 ◽  
Author(s):  
Rita Nizzoli ◽  
Annamaria Guazzi ◽  
Nadia Naldi ◽  
Vittorio Franciosi ◽  
Cecilia Bozzetti
Keyword(s):  
Breast Cancer ◽  
In Situ Hybridization ◽  
Metastatic Breast Cancer ◽  
Fluorescence In Situ Hybridization ◽  
Metastatic Breast ◽  
Her 2

scholarly journals Quantitative HER2 protein levels predict outcome in fluorescence in situ hybridization-positive patients with metastatic breast cancer treated with trastuzumab

Cancer ◽  
2010 ◽  
Vol 116 (22) ◽  
pp. 5168-5178 ◽  
Author(s):  
Allan Lipton ◽  
Wolfgang J. Köstler ◽  
Kim Leitzel ◽  
Suhail M. Ali ◽  
Jeff Sperinde ◽  
...  
Keyword(s):  
Breast Cancer ◽  
In Situ Hybridization ◽  
Metastatic Breast Cancer ◽  
Fluorescence In Situ Hybridization ◽  
Metastatic Breast ◽  
Her2 Protein ◽  
Protein Levels
Sign in / Sign up

Export Citation Format

Share Document